Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration

Abstract

Tuberous sclerosis complex (TSC) is a tumor suppressor gene syndrome characterized by seizures, mental retardation, autism, and tumors of the brain, kidney, heart, retina, and skin. TSC is caused by mutations in either TSC1 or TSC2, both of which are tumor suppressor genes. Hamartin, the protein product of TSC1, was found to interact with the ezrin-radixin-moesin family of cytoskeletal proteins and to activate the small GTPase Rho. To determine whether tuberin, the TSC2 product, can also activate Rho, we stably expressed full-length human tuberin in two cell types: MDCK cells and ELT3 cells. ELT3 cells lack endogenous tuberin expression. We found that expression of human tuberin in both MDCK and ELT3 cells was associated with an increase in the amount of Rho-GTP, but not in Rac1-GTP or cdc42-GTP. Tuberin expression increased cell adhesion in both cell types, and decreased chemotactic cell migration in ELT3 cells. In MDCK cells, there was a decrease in the amount of total Focal Adhesion Kinase (FAK) and an increase in the fraction of phosphorylated FAK. These findings demonstrate for the first time that tuberin activates Rho and regulates cell adhesion and migration. Pathways involving Rho activation may have relevance to the clinical manifestations of TSC, including pulmonary lymphangioleiomyomatosis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Agochiya M, Brunton VG, Owens DW, Parkinson EK, Paraskeva C, Keith WN, Frame MC . 1999 Oncogene 18: 5646–5653

  • Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, Halley DJ, Sampson JR, Wienecke R, DeClue JE . 2000 Oncogene 19: 6306–6316

  • Bobak D, Moorman J, Guanzon A, Gilmer L, Hahn C . 1997 Oncogene 15: 2179–2189

  • Bonifacino J, Dasso M, Harford J, Lippincott-Schwartz J, Yamada K . 2001 Current protocols in cell biology New York: John Wiley and Sons, Inc

    Book  Google Scholar 

  • Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L . 2000 Clin. Cancer Res. 6: 2417–2423

  • Carsillo T, Astrinidis A, Henske EP . 2000 Proc. Natl. Acad. Sci. USA 97: 6085–6090

  • Clark EA, Golub TR, Lander ES, Hynes RO . 2000 Nature 406: 532–535

  • Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D, Kwiatkowski DJ . 2001 Am. J. Hum. Genet. 68: 64–80

  • European chromosome 16 Tuberous Sclerosis Consortium. 1993 Cell 75: 1305–1315

  • Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA, Collard JG . 2000 Eur. J. Cancer 36: 1269–1274

  • Flinn HM, Ridley AJ . 1996 J. Cell Sci. 109: 1133–1141

  • Gomez M, Sampson JR, Whittemore VH (eds) . 1999 Tuberous Sclerosis Complex 3rd edn New York: Oxford University Press

    Google Scholar 

  • Henry KW, Yuan X, Koszewski NJ, Onda H, Kwiatkowski DJ, Noonan DJ . 1998 J. Biol. Chem. 273: 20535–20539

  • Hodges AK, Li S, Maynard J, Parry L, Braverman R, Cheadle JP, DeClue JE, Sampson JR . 2001 Hum. Mol. Genet. 10: 2899–2905

  • Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker C . 1995 Am. J. Pathol. 146: 1568–1579

  • Ilic D, Damsky CH, Yamamoto T . 1997 J. Cell Sci. 110: 401–407

  • Irani C, Goncharova EA, Hunter DS, Walker CL, Panettieri RA, Krymskaya VP . 2002 Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L854–L862

  • Ito N, Rubin GM . 1999 Cell 96: 529–539

  • Judson PL, He X, Cance WG, Van Le L . 1999 Cancer 86: 1551–1556

  • Kobayashi R, Hirayama Y, Kobayashi E, Kubo Y, Hino O . 1995 Nat. Genet. 9: 70–74

  • Kornberg LJ . 1998 Head Neck 20: 745–752

  • Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, Hall A . 2000 Nat. Cell. Biol. 2: 281–287

  • Miloloza A, Rosner M, Nellist M, Halley D, Bernaschek G, Hengstschlager M . 2000 Hum. Mol. Genet. 9: 1721–1727

  • Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, van Den Ouweland AM, Halley DJ . 2001 Hum. Mol. Genet. 10: 2889–2898

  • Plank TL, Yeung RS, Henske EP . 1998 Cancer Res. 58: 4766–4770

  • Potter CJ, Huang H, Xu T . 2001 Cell 105: 357–368

  • Reid T, Furuyashiki T, Ishizaki T, Watanabe G, Watanabe N, Fujisawa K, Morii N, Madaule P, Narumiya S . 1996 J. Biol. Chem. 271: 13556–13560

  • Royal I, Lamarche-Vane N, Lamorte L, Kaibuchi K, Park M . 2000 Mol. Biol. Cell 11: 1709–1725

  • Sastry SK, Burridge K . 2000 Exp. Cell. Res. 261: 25–36

  • Schmitz AA, Govek EE, Bottner B, Van Aelst L . 2000 Exp. Cell Res. 261: 1–12

  • Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD . 2000 Nat. Cell. Biol. 2: 249–256

  • Sinnett-Smith J, Lunn JA, Leopoldt D, Rozengurt E . 2001 Exp. Cell Res. 266: 292–302

  • Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M . 1997 J. Biol. Chem. 272: 29301–29308

  • Sullivan EJ . 1998 Chest 114: 1689–1703

  • Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK . 2001 Cell 105: 345–355

  • Timpson P, Jones GE, Frame MC, Brunton VG . 2001 Curr. Biol. 11: 1836–1846

  • van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell R, Cheadle J, Jones A, Tachataki M, Ravine D, Sampson J, Reeve M, Richardson P, Wilmer R, Munro C, Hawkins T, Sepp T, Ali J, Ward S, Green A, Yates J, Kwiatkowska J, Henske E, Short M, Haines J, Jozwiak S, Kwiatkowski D . 1997 Science 277: 805–808

  • van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P . 1998 Hum. Mol. Genet. 7: 1053–1057

  • Weiner TM, Liu ET, Craven RJ, Cance WG . 1993 Lancet 342: 1024–1025

  • Wienecke R, Konig A, DeClue JE . 1995 J. Biol. Chem. 270: 16409–16414

  • Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS . 1997 J. Biol. Chem. 272: 6097–6100

  • Yeung RS, Xiao GH, Everitt JI, Jin F, Walker CL . 1995 Mol. Carcinog. 14: 28–36

  • Yeung RS, Xiao GH, Jin F, Lee WC, Testa JR, Knudson AG . 1994 Proc. Natl. Acad. Sci. USA 91: 11413–11416

  • Yu J, Astrinidis A, Henske EP . 2001 Am. J. Respir. Crit. Care Med. 164: 1537–1540

Download references

Acknowledgements

We are grateful to Drs Erica Golemis and Joseph Testa for critical review of this manuscript. This work was supported by NIH grants HL 60746 and DK 51052, and the LAM Foundation (Cincinnati, OH, USA).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth P Henske.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Astrinidis, A., Cash, T., Hunter, D. et al. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene 21, 8470–8476 (2002). https://doi.org/10.1038/sj.onc.1205962

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205962

Keywords

This article is cited by

Search

Quick links